CAP-1, PF-3450074 and peptide NYAD-1 (a conformationally restricted derivative of CAI [18]), were able to penetrate cultured cells and inhibit HIV-1 infection ex vivo. This evidence concerns the gene CA1 and HIV-1 infection.